532 related articles for article (PubMed ID: 15925834)
1. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
Cui Z; Zhao MH
Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
[TBL] [Abstract][Full Text] [Related]
2. [Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage].
Cui Z; Zhao MH
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):903-7. PubMed ID: 16029529
[TBL] [Abstract][Full Text] [Related]
3. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
5. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
6. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY
Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023
[TBL] [Abstract][Full Text] [Related]
7. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569
[TBL] [Abstract][Full Text] [Related]
8. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
9. The functional affinity and specificity of autoantibodies in animal models of anti-glomerular basement membrane disease.
Marriott JB; Qasim F; Reynolds J; Pusey CD; Oliveira DB
Exp Nephrol; 1995; 3(4):257-64. PubMed ID: 8590039
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
Thorner PS; Baumal R; Eddy A; Marrano P
Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812
[TBL] [Abstract][Full Text] [Related]
11. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
12. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
13. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity.
Zhao J; Yan Y; Cui Z; Yang R; Zhao MH
Hum Immunol; 2009 Jun; 70(6):425-9. PubMed ID: 19364515
[TBL] [Abstract][Full Text] [Related]
14. Development and application of an ELISA for Goodpasture's disease based on sheep alpha 3(IV)NC1 domains.
Katbamna I; Turner N; Ross CN; Pusey CD
J Clin Lab Immunol; 1995; 47(1):11-24. PubMed ID: 8735432
[TBL] [Abstract][Full Text] [Related]
15. Natural autoantibodies against glomerular basement membrane exist in normal human sera.
Cui Z; Wang HY; Zhao MH
Kidney Int; 2006 Mar; 69(5):894-9. PubMed ID: 16518348
[TBL] [Abstract][Full Text] [Related]
16. [Epitope mapping of anti-glomerular basement membrane antibodies].
Ding J; Zhao M; Wang H
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):863-5. PubMed ID: 11702682
[TBL] [Abstract][Full Text] [Related]
17. Anti-GBM disease: predictive value of clinical, histological and serological data.
Herody M; Bobrie G; Gouarin C; Grünfeld JP; Noel LH
Clin Nephrol; 1993 Nov; 40(5):249-55. PubMed ID: 8281713
[TBL] [Abstract][Full Text] [Related]
18. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.
Salama AD; Dougan T; Levy JB; Cook HT; Morgan SH; Naudeer S; Maidment G; George AJ; Evans D; Lightstone L; Pusey CD
Am J Kidney Dis; 2002 Jun; 39(6):1162-7. PubMed ID: 12046026
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease.
Cui Z; Zhao MH; Xin G; Wang HY
Nephron Clin Pract; 2005; 99(2):c49-55. PubMed ID: 15637429
[TBL] [Abstract][Full Text] [Related]
20. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
